In a meta-analysis of seven studies published in
the January issue of Laryngoscope, Ji Ho Choi, M.D., Ph. D., and coauthors
conclude that the Medtronic Pillar Procedure significantly reduced snoring
loudness and mild-to-moderate obstructive sleep apnea (OSA).
The Medtronic Pillar Procedure was cleared by the Food and Drug Administration
(FDA) as a treatment for snoring in 2002 and for mild-to-moderate OSA in
2004. A minimally invasive, tissue-sparing procedure, doctors perform the
Pillar Procedure as an alternative to more invasive surgical procedures to
remove obstructive tissues in the upper airway that contribute to snoring and
OSA.
Choi and his colleagues write, "Various surgical procedures on the upper
airway have been attempted for snoring and OSA. Yet their effect remains
equivocal. This is mainly because of a shortage of evidence on the surgical
results and the absence of definitive criteria about surgical success."
For their analysis of the effect of the Pillar Procedure on snoring, Choi and
his colleagues used seven case-controlled studies, with a total enrollment of
174 subjects. These studies all used the post-procedure Visual Analogue Scale
(VAS) score compared to the pre-procedure score as their primary outcome
measure. VAS is a measure of snoring intensity. The meta-analysis results
indicate that the Pillar implant reduced snoring sound significantly as
compared to preprocedure values with a standardized mean difference of -0.591
(p<0.001).
Study authors also analyzed the efficacy of the Pillar procedure as a single
surgical procedure for the treatment of mild to moderate OSA. The seven
selected studies included five case series and two placebo-controlled trials.
The total number of subjects enrolled in the seven studies was 363, of which
76 were in placebo control groups.
The primary OSA outcome measures for the seven selected studies included the
Epworth Sleepiness Scale (ESS), and the Apnea-Hypopnea Index (AHI).
The ESS is a questionnaire completed by each person who self-identifies his or
her likelihood of falling asleep during the day in eight different situations.
AHI is a measure of the mean number of times a person experiences an episode
of apnea or hypopnea (partial or complete blockage of the airway) during an
hour of sleep. The results of the meta-analysis indicate that the Pillar
implant significantly reduced ESS as compared to preprocedure values with a
standardized mean difference of -0.481 (p<0.001), and significantly reduced
AHI as compared to preprocedure values with a standardized mean difference of
-0.378 (p=0.002).
The authors' study, "Efficacy of the Pillar Implant in the Treatment of
Snoring and Mild-to-Moderate Obstructive Sleep Apnea: a Meta-Analysis," can
also be read online at www.laryngoscope.com.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in